LumiraDx shares these and other findings from its second annual U.S. survey “Point of Care Diagnostics: A Clinician's View” WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: ...

Point-of-care testing (POCT) for sexually transmitted infections offers rapid, decentralised diagnostics that inform clinical decisions within a single visit. Traditionally, laboratory-based nucleic ...

Point-of-care-testing for suspected COVID-19 reduces time to results and may improve infection control, suggesting these tests might have clinical advantages over widely used laboratory PCR methods.

Salvatore Viscomi MD, co-founder of Carna Health is an entrepreneur with a passion for digital health and remote patient monitoring. The Covid-19 pandemic taught us that providing care outside of ...

The company’s focus on high accuracy POCT testing reagents aligns precisely with this demand, integrating robust quality control, innovative biochemistry, and user-centered design. Moreover, the ...

After the COVID-19 pandemic, fever clinics urgently require rapid nucleic acid tests to enhance their capacity for timely pathogen detection. This study evaluated the ...

Large scale deployment of rapid, low-cost, hand-held point of care testing devices for diagnosing infectious diseases is critical for improving global health. Recent advances in engineering and ...

DUBLIN, Dec. 15, 2020 /PRNewswire/ -- The "Global Point-of-Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases), Outlook 2022" report has been added to ...

WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (LMDX), a next-generation point of care diagnostics company, today announced findings from its second annual “Point of Care ...

NINGBO, ZHEJIANG, CHINA, February 3, 2026 /EINPresswire.com/ — Ningbo Qinmeng Maternal and Child Products Co., Ltd., a subsidiary of Ningbo Ciliang Import and ...